Halozyme Therapeutics
HALO
#2053
Rank
S$10.04 B
Marketcap
$81.57
Share price
0.28%
Change (1 day)
48.11%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of December 2024 : S$2.01 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is S$2.01 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2024-12-31S$2.04 B3.37%
2023-12-31S$1.98 B-1.93%
2022-12-31S$2.01 B70.36%
2021-12-31S$1.18 B125.53%
2020-12-31S$0.52 B-3.18%
2019-12-31S$0.54 B214.36%
2018-12-31S$0.17 B-36.21%
2017-12-31S$0.27 B-13.67%
2016-12-31S$0.31 B344.76%
2015-12-31S$70.49 M6.99%
2014-12-31S$65.88 M4.47%
2013-12-31S$63.06 M65.75%
2012-12-31S$38.04 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$63.71 M-96.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$44.94 B 2,134.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.96 B 793.15%๐Ÿ‡บ๐Ÿ‡ธ USA
S$85.02 B 4,126.92%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.89 B 1,137.44%๐Ÿ‡ซ๐Ÿ‡ท France
S$48.93 B 2,332.86%๐Ÿ‡บ๐Ÿ‡ธ USA